Home
About
Clinical Research
Blog
News
Join Us
Contact

Sitemap

Home
About
Clinical Research
Blog
Careers
Contact
News

Latest News

Magnus Medical Announces American Medical Association Issues New CPT Category III Codes for Targeted, Accelerated Intermittent Theta-Burst Stimulation

Researchers investigate new revolutionary 5-day therapy for treatment-resistant depression

Join Us

We are looking for individuals who are personally and boldly committed to improving treatment for mental health.

View open positions HERE

We Are Social

Rx Only
The SAINT® Neuromodulation System is indicated for the treatment of Major Depressive Disorder (MDD) in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. The SAINT Neuromodulation System is contraindicated for: patients with non-removable conductive, ferromagnetic, or other magnetic-sensitive metal anywhere in the head or within 30cm of the stimulation coil; patients who have an active or inactive implanted device; or patients with increased intracranial pressure or intracardiac lines, intravenous pumps, or dose calculators. Consult product labeling for a complete list of contraindications, warnings, and precautions. Side effects including headache, fatigue, anxiety, and treatment-site discomfort were shown in clinical trials. Risks associated with transcranial magnetic stimulation, including seizure and worsening depression or suicidality, may exist. Results may vary.

Financial Conflict of Interest Policy

Sitemap

© 2023 Magnus Medical and The Board of Trustees of the Leland Stanford Junior University. MAGNUS MEDICAL and the MAGNUS MEDICAL Logo are the trademarks of Magnus Medical, Inc. SAINT, the SAINT Logo and SNT are used under license from Stanford University.